Health
Beckman Coulter Launches Semi-Quantitative Access SARS-CoV-2 IgG II Antibody Test – HospiMedica
Beckman Coulter Diagnostics (Brea, CA, USA) has launched its Access SARS-CoV-2 IgG II assay that measures a patient’s relative level of antibodies in response to…
Beckman Coulter Diagnostics (Brea, CA, USA) has launched its Access SARS-CoV-2 IgG II assay that measures a patients relative level of antibodies in response to a previous SARS-CoV-2 infection. The assays new capabilities enable clinicians to establish a baseline to evaluate an individuals immune response to the SARS-CoV-2 virus based on a numerical value and assess relative changes of an individuals immune response to the virus over time. The assay may also help researchers as they begin to understand…
-
Noosa News23 hours agoWhy Brisbane needs to (re)embrace Los Angeles
-
Noosa News20 hours agoTayla Harris stars as Melbourne defeats Essendon by 14 points
-
General23 hours agoAustralia retains Chappell-Hadlee Trophy after rain washes out second T20I against New Zealand
-
General22 hours agoUK names Sarah Mullally as first female Archbishop of Canterbury to lead Church of England